石药创新
(300765)
| 流通市值：623.64亿 | | | 总市值：623.64亿 |
| 流通股本：14.05亿 | | | 总股本：14.05亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,240,242,226.11 | 664,646,761.85 | 2,157,680,212.7 | 1,593,014,097.66 |
| 营业收入 | 3,240,242,226.11 | 664,646,761.85 | 2,157,680,212.7 | 1,593,014,097.66 |
| 二、营业总成本 | 1,709,236,865.3 | 793,983,206.85 | 2,768,620,899.67 | 1,914,330,227.48 |
| 营业成本 | 753,550,258.41 | 391,166,567.77 | 1,329,764,478.27 | 960,862,549.97 |
| 税金及附加 | 16,658,160.53 | 8,644,339.5 | 32,534,965.97 | 24,483,019.52 |
| 销售费用 | 160,121,251.08 | 70,320,245.55 | 281,251,612.66 | 201,949,706.57 |
| 管理费用 | 62,270,273.16 | 29,783,566.02 | 96,186,212.48 | 64,144,771.03 |
| 研发费用 | 663,583,827.01 | 273,278,688.55 | 1,036,010,968.67 | 683,435,255.69 |
| 财务费用 | 53,053,095.11 | 20,789,799.46 | -7,127,338.38 | -20,545,075.3 |
| 其中:利息费用 | 24,288,203.28 | 14,134,482.26 | 21,817,376.5 | 14,144,090.91 |
| 其中:利息收入 | 10,396,363.65 | 4,050,119.3 | 11,061,218.57 | 16,495,173.8 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 5,954,210.29 | 1,577,747.35 | 17,968,873.4 | 448,458.33 |
| 加:投资收益 | -193,291.44 | -5,050,042.12 | -14,112,785.93 | -8,433,697.76 |
| 资产处置收益 | -262,554.51 | -18,577.1 | 2,782,751.39 | 1,753,198.41 |
| 资产减值损失(新) | -4,603,562.05 | - | -14,154,894.24 | -598.07 |
| 信用减值损失(新) | -2,803,249.03 | -5,518,248.73 | -7,937,429.17 | -8,581,156.95 |
| 其他收益 | 41,952,848.35 | 19,858,920.01 | 80,981,096.75 | 74,444,840.99 |
| 四、营业利润 | 1,571,049,762.42 | -118,486,645.59 | -545,413,074.77 | -261,685,084.87 |
| 加:营业外收入 | 795,954.62 | 119,344.15 | 3,020,765.8 | 2,849,072.91 |
| 减:营业外支出 | 2,134,707.88 | 1,238,123.95 | 9,145,173.89 | 6,735,929.97 |
| 五、利润总额 | 1,569,711,009.16 | -119,605,425.39 | -551,537,482.86 | -265,571,941.93 |
| 减:所得税费用 | 18,257,467.25 | 10,260,912.36 | 57,798,547.84 | 44,676,660.7 |
| 六、净利润 | 1,551,453,541.91 | -129,866,337.75 | -609,336,030.7 | -310,248,602.63 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 1,551,453,541.91 | -129,866,337.75 | -609,336,030.7 | -310,248,602.63 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 1,261,185,991.32 | -93,854,748.19 | -241,125,740.52 | -24,048,877.47 |
| 少数股东损益 | 290,267,550.59 | -36,011,589.56 | -368,210,290.18 | -286,199,725.16 |
| 扣除非经常损益后的净利润 | 1,225,931,718.53 | -111,071,889.68 | -294,413,898.37 | -64,820,945.93 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.91 | -0.07 | -0.17 | -0.02 |
| (二)稀释每股收益 | 0.91 | -0.07 | -0.17 | -0.02 |
| 八、其他综合收益 | -4,069,430.97 | -2,192,512.84 | 1,766,934.17 | 2,527,609.18 |
| 归属于母公司股东的其他综合收益 | -4,069,430.97 | -2,192,512.84 | 1,766,934.17 | 2,527,609.18 |
| 九、综合收益总额 | 1,547,384,110.94 | -132,058,850.59 | -607,569,096.53 | -307,720,993.45 |
| 归属于母公司股东的综合收益总额 | 1,257,116,560.35 | -96,047,261.03 | -239,358,806.35 | -21,521,268.29 |
| 归属于少数股东的综合收益总额 | 290,267,550.59 | -36,011,589.56 | -368,210,290.18 | -286,199,725.16 |
| 公告日期 | 2026-08-18 | 2026-04-28 | 2026-03-17 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |